NNC0487-0111

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for NNC0487-0111, covering 2025-03-30 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight [Phase 3]

See pricing